Diuretic medication and change in fluid retention biomarkers during treatment with the endothelin receptor antagonist atrasentan.

Authors :: Smeijer JD
Kohan DE
de Zeeuw D
Heerspink HJL
Source :: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2023 Aug; Vol. 25 (8), pp. 2419-2422. Date of Electronic Publication: 2023 May 08.
Publication Year :: 2023

Subjects :: Humans
Atrasentan therapeutic use
Endothelin Receptor Antagonists therapeutic use
Diuretics therapeutic use
Endothelin A Receptor Antagonists therapeutic use
Pyrrolidines therapeutic use
Biomarkers
Heart Failure drug therapy
Diabetic Nephropathies drug therapy

Full Text Access

Tools